Ekso Bionics Holdings, Inc. (OTCQB: EKSO) is up as much as 11.45% today in the first hour of trading.
That first hour of trading has also seen the stock with more than it’s typical full day volume. So far 517k shares have traded just 60 minutes into the day. That compares to the typical volume average of 436k over the past 30 days.
Ekso Bionics is an incredible company with an incredible product.
Ekso Bionics helps survivors of stroke, spinal cord injury and other forms of lower extremity weakness to walk again. The Ekso GT™ robotic exoskeleton has changed the course of recovery in gait training and neurorehabilitation by augmenting not only the individual’s strength, but the therapist’s ability to work with their patients.
From a Press Release on August 11th:
SECOND QUARTER AND RECENT HIGHLIGHTS
- We recognized revenue of $2.1 million for the three months ended June 30, 2015, compared to $1.2 million for the same period of 2014.
- We shipped a net 17 new units in the three months ended June 30, 2015, as compared to 15 units for the same period of 2014. We have now sold or rented over 145 medical devices to over 100 customers.
- We have recorded over 21,000 patient sessions with a total of 26.5 million steps, an increase of 16.5 million from one year ago.
- We announced our SmartAssist software upgrade, the next generation of Variable Assist, as well as FES integration module, to be released in Europe this fall.
- We held the first Exoskeleton Clinical Science Organization (ECSO) meeting; this group will lay the groundwork for the clinical evidence roadmap necessary to become part of standard of care treatment.
- We now hold 12 U.S. patents and have an additional 40 U.S. patent applications filed. These have generated an additional 40 internationally issued patents and 49 international applications filed.